These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24363042)

  • 1. Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats.
    Abdel-Raheem IT; Khedr NF
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):341-53. PubMed ID: 24363042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
    Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
    Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast protects against renal ischemia/reperfusion injury in rats.
    Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC
    Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
    Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
    Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats.
    Otunctemur A; Ozbek E; Cakir SS; Dursun M; Cekmen M; Polat EC; Ozcan L; Somay A; Ozbay N
    Int Braz J Urol; 2015; 41(2):279-87. PubMed ID: 26005969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of montelukast against amikacin-induced acute renal damage.
    Kose E; Beytur A; Dogan Z; Ekincioglu Z; Vardi N; Cinar K; Turkoz Y; Soysal H; Ekinci N
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):503-11. PubMed ID: 22696878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of pentoxyfilline in renal toxicity after methotrexate administration.
    Asvadi I; Hajipour B; Asvadi A; Asl NA; Roshangar L; Khodadadi A
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1003-9. PubMed ID: 22013722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs.
    Sener G; Kabasakal L; Cetinel S; Contuk G; Gedik N; Yeğen BC
    Burns; 2005 Aug; 31(5):587-96. PubMed ID: 15935562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
    Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant and anti-inflammatory effects of virgin coconut oil supplementation abrogate acute chemotherapy oxidative nephrotoxicity induced by anticancer drug methotrexate in rats.
    Famurewa AC; Aja PM; Maduagwuna EK; Ekeleme-Egedigwe CA; Ufebe OG; Azubuike-Osu SO
    Biomed Pharmacother; 2017 Dec; 96():905-911. PubMed ID: 29224791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of peroxisome proliferator activator receptor (PPAR)-α and -γ ligands against methotrexate-induced nephrotoxicity.
    Ibrahim MA; El-Sheikh AA; Khalaf HM; Abdelrahman AM
    Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):130-7. PubMed ID: 24521009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production.
    Helmy MM; El-Gowelli HM
    Eur J Pharmacol; 2012 May; 683(1-3):294-300. PubMed ID: 22449377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotective effect of celecoxib against gentamicin-induced nephrotoxicity through suppressing NFκB and caspase-3 signaling pathways in rats.
    Abdelrahman RS; Abdelmageed ME
    Chem Biol Interact; 2020 Jan; 315():108863. PubMed ID: 31628940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney.
    Otunctemur A; Ozbek E; Cekmen M; Cakir SS; Dursun M; Polat EC; Somay A; Ozbay N
    Ren Fail; 2013; 35(3):403-10. PubMed ID: 23342977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of sepsis-induced pancreatic injury by leukotriene receptor antagonism via modulation of oxidative injury, and downregulation of inflammatory markers in experimental rats.
    Hagar HH; Alhazmi SM; Arafah M; Bayoumy NM
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3425-3435. PubMed ID: 37962585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of montelukast against cisplatin-induced acute renal damage in rats.
    Beytur A; Köse E; Sarihan ME; Sapmaz HI; Dogan Z; Cetin A; Vardi N; Turkoz Y; Ekinci N
    Ren Fail; 2012; 34(3):343-9. PubMed ID: 22260262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of poly(ADP-ribose) polymerase (PARP) activation in methotrexate-induced nephrotoxicity and tubular apoptosis.
    Dalaklioglu S; Sahin P; Ordueri EG; Celik-Ozenci C; Tasatargil A
    Int J Toxicol; 2012; 31(5):430-40. PubMed ID: 22914891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil infiltration and oxidative stress may play a critical role in methotrexate-induced renal damage.
    Kolli VK; Abraham P; Isaac B; Selvakumar D
    Chemotherapy; 2009; 55(2):83-90. PubMed ID: 19145077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of alamandine on doxorubicin‑induced nephrotoxicity in rats.
    Soltani Hekmat A; Chenari A; Alipanah H; Javanmardi K
    BMC Pharmacol Toxicol; 2021 May; 22(1):31. PubMed ID: 34049594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
    Al-Amran FG; Hadi NR; Hashim AM
    Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.